One of the most important developments in the field of cardiovascular medicine over the last two decades has been recognition of the key role played by arterial thrombosis in the pathogenesis of acute coronary syndromes, ischemic complications of percutane- ous coronary revascularization, and coronary and peripheral atherosclerosis. The phar- macologic armamentarium directed against vascular thrombosis has thus expanded substantially during that time, with development of new fibrinolytic agents, low-molecu- lar-weight ...
Read More
One of the most important developments in the field of cardiovascular medicine over the last two decades has been recognition of the key role played by arterial thrombosis in the pathogenesis of acute coronary syndromes, ischemic complications of percutane- ous coronary revascularization, and coronary and peripheral atherosclerosis. The phar- macologic armamentarium directed against vascular thrombosis has thus expanded substantially during that time, with development of new fibrinolytic agents, low-molecu- lar-weight heparins, direct thrombin inhibitors, antagonists to platelet activation, and the platelet glycoprotein lIb/IlIa inhibitors. Though clinical investigations of these com- pounds have been marked by failures as well as successes, there is little doubt that enhanced antithrombotic therapies have markedly improved the outcome of patients undergoing coronary revascularization or with acute coronary syndromes. Glycoprotein IIblIlIa receptor antagonists were introduced into clinical practice to overcome the limitations of approaches that inhibit only individual pathways of platelet activation. Multiple mechanisms of platelet activation in response to different agonists converge on the platelet membrane glycoprotein IIblIlIa complex, the "final common pathway" of platelet aggregation. The clinical hemorrhagic syndrome caused by a rare inherited defect in this receptor (Glanzmann' s thrombasthenia), characterized by muco- cutaneous and postsurgical bleeding, but infrequent spontaneous organ (particularly central nervous system) bleeding, suggested that therapeutic inhibition of this receptor might be a potent, yet well-tolerated means of treating thrombotic disorders.
Read Less
Add this copy of Platelet Glycoprotein IIb/IIIa Inhibitors in to cart. $243.84, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2010 by Humana Press Inc..
Add this copy of Platelet Glycoprotein Iib/Iiia Inhibitors in to cart. $55.64, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2009 by Humana Press Inc.
Add this copy of Platelet Glycoprotein Iib/Iiia Inhibitors in to cart. $23.48, good condition, Sold by JUGGERNAUTZ rated 4.0 out of 5 stars, ships from East Grand Rapids, MI, UNITED STATES, published 2003 by Humana.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Good. Used texts DO NOT include any supplemental material such as; online access codes, CDs, etc. All text is legible and may contain; markings, highlighting, worn-corners, folded pages, etc, from typical use. Orders ship same or next business day w/ free tracking. Choose Expedited shipping for fastest (2-6 business day) delivery. Satisfaction Guaranteed!
Add this copy of Platelet Glycoprotein Iib/Iiia Inhibitors in to cart. $144.72, new condition, Sold by discount_scientific_books rated 5.0 out of 5 stars, ships from Sterling Heights, MI, UNITED STATES, published 2003 by Humana.
Add this copy of Platelet Glycoprotein Iib/Iiia Inhibitors in to cart. $213.71, new condition, Sold by Media Smart rated 4.0 out of 5 stars, ships from Hawthorne, CA, UNITED STATES, published 2003 by Humana Press.
Add this copy of Platelet Glycoprotein Iib/Iiia Inhibitors in to cart. $215.66, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2003 by Humana.
Add this copy of Platelet Glycoprotein Iib/Iiia Inhibitors in to cart. $21.50, like new condition, Sold by Bingo Used Books rated 4.0 out of 5 stars, ships from Vancouver, WA, UNITED STATES, published 1999 by Totowa, New Jersey, U.S.A. : Humana Pr Inc.
Add this copy of Platelet Glycoprotein Iib/Iiia Inhibitors in to cart. $24.50, very good condition, Sold by HPB-Emerald rated 4.0 out of 5 stars, ships from Dallas, TX, UNITED STATES, published 1999 by Totowa, New Jersey, U.S.A. : Huma.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
Add this copy of Platelet Glycoprotein Iib/Iiia Inhibitors in to cart. $24.50, good condition, Sold by HPB-Red rated 5.0 out of 5 stars, ships from Dallas, TX, UNITED STATES, published 1999 by Totowa, New Jersey, U.S.A. : Huma.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
